NO135181B - - Google Patents
Download PDFInfo
- Publication number
- NO135181B NO135181B NO998/72A NO99872A NO135181B NO 135181 B NO135181 B NO 135181B NO 998/72 A NO998/72 A NO 998/72A NO 99872 A NO99872 A NO 99872A NO 135181 B NO135181 B NO 135181B
- Authority
- NO
- Norway
- Prior art keywords
- acid
- glucamine
- solution
- salts
- monoalkyl
- Prior art date
Links
- RDFJFVXMRYVOAC-UHFFFAOYSA-N methiodal Chemical class OS(=O)(=O)CI RDFJFVXMRYVOAC-UHFFFAOYSA-N 0.000 claims description 12
- 150000003839 salts Chemical class 0.000 claims description 9
- 125000004432 carbon atom Chemical group C* 0.000 claims description 8
- 229960003695 methiodal Drugs 0.000 claims description 7
- 239000002872 contrast media Substances 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 229910052799 carbon Inorganic materials 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 8
- 229910052740 iodine Inorganic materials 0.000 description 8
- 239000011630 iodine Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 239000002253 acid Substances 0.000 description 6
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 4
- 239000012266 salt solution Substances 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- CUGDYSSBTWBKII-LXGUWJNJSA-N (2r,3r,4r,5s)-6-(dimethylamino)hexane-1,2,3,4,5-pentol Chemical compound CN(C)C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO CUGDYSSBTWBKII-LXGUWJNJSA-N 0.000 description 3
- 206010002091 Anaesthesia Diseases 0.000 description 3
- -1 Iodomethanesulphonic acid N-methylglucamine Chemical compound 0.000 description 3
- 230000037005 anaesthesia Effects 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000001949 anaesthesia Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- SDWBDPJSRFXRJO-UHFFFAOYSA-N iodomethanesulfonic acid;sodium Chemical compound [Na].OS(=O)(=O)CI SDWBDPJSRFXRJO-UHFFFAOYSA-N 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- VQSVOQJUFSROBP-LXGUWJNJSA-N (2r,3r,4r,5s)-6-(2-hydroxyethylamino)hexane-1,2,3,4,5-pentol Chemical compound OCCNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO VQSVOQJUFSROBP-LXGUWJNJSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- LHIJANUOQQMGNT-UHFFFAOYSA-N aminoethylethanolamine Chemical compound NCCNCCO LHIJANUOQQMGNT-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 238000002690 local anesthesia Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000009608 myelography Methods 0.000 description 1
- 210000000944 nerve tissue Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 210000000115 thoracic cavity Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19712117014 DE2117014A1 (de) | 1971-04-02 | 1971-04-02 | Salze der Jodmethansulfonsaure mit organischen Basen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO135181B true NO135181B (de) | 1976-11-15 |
| NO135181C NO135181C (de) | 1977-02-23 |
Family
ID=5804147
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO998/72A NO135181C (de) | 1971-04-02 | 1972-03-24 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US3937733A (de) |
| AT (2) | AT323121B (de) |
| AU (1) | AU467239B2 (de) |
| BE (1) | BE781587A (de) |
| CA (1) | CA999880A (de) |
| CH (1) | CH579031A5 (de) |
| DE (1) | DE2117014A1 (de) |
| DK (1) | DK131934C (de) |
| FR (1) | FR2132352B1 (de) |
| GB (1) | GB1387175A (de) |
| IL (1) | IL39005A (de) |
| NL (1) | NL7204492A (de) |
| NO (1) | NO135181C (de) |
| SE (1) | SE391519B (de) |
| ZA (1) | ZA722184B (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5282827A (en) * | 1991-11-08 | 1994-02-01 | Kensey Nash Corporation | Hemostatic puncture closure system and method of use |
| US5676689A (en) * | 1991-11-08 | 1997-10-14 | Kensey Nash Corporation | Hemostatic puncture closure system including vessel location device and method of use |
| US8961541B2 (en) * | 2007-12-03 | 2015-02-24 | Cardio Vascular Technologies Inc. | Vascular closure devices, systems, and methods of use |
| US20090143808A1 (en) * | 2001-04-24 | 2009-06-04 | Houser Russell A | Guided Tissue Cutting Device, Method of Use and Kits Therefor |
| US20080114394A1 (en) * | 2001-04-24 | 2008-05-15 | Houser Russell A | Arteriotomy Closure Devices and Techniques |
| US8992567B1 (en) | 2001-04-24 | 2015-03-31 | Cardiovascular Technologies Inc. | Compressible, deformable, or deflectable tissue closure devices and method of manufacture |
| WO2010118312A2 (en) | 2009-04-09 | 2010-10-14 | Cardiovascular Systems, Inc. | Tissue closure devices, device and systems for delivery, kits and methods therefor |
| DE102017117748B9 (de) | 2017-08-04 | 2019-03-14 | Tdk Electronics Ag | Verbindung eines Anschlussdrahtes mit einem Anschlusselement |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB353477A (en) * | 1930-04-24 | 1931-07-24 | Ig Farbenindustrie Ag | Process for the manufacture of iodo methane sulphonic acid and salts thereof |
| FR708270A (fr) * | 1930-12-23 | 1931-07-22 | Ig Farbenindustrie Ag | Production d'acide iodeméthanesulfonique ou de ses homologues |
-
1971
- 1971-04-02 DE DE19712117014 patent/DE2117014A1/de active Pending
-
1972
- 1972-03-16 IL IL39005A patent/IL39005A/en unknown
- 1972-03-21 DK DK132572A patent/DK131934C/da active
- 1972-03-22 CH CH425972A patent/CH579031A5/xx not_active IP Right Cessation
- 1972-03-24 NO NO998/72A patent/NO135181C/no unknown
- 1972-03-27 GB GB1416372A patent/GB1387175A/en not_active Expired
- 1972-03-29 SE SE7204128A patent/SE391519B/xx unknown
- 1972-03-30 AT AT250573A patent/AT323121B/de not_active IP Right Cessation
- 1972-03-30 CA CA138,655A patent/CA999880A/en not_active Expired
- 1972-03-30 ZA ZA722184A patent/ZA722184B/xx unknown
- 1972-03-30 AT AT279072A patent/AT312795B/de not_active IP Right Cessation
- 1972-03-30 AU AU40634/72A patent/AU467239B2/en not_active Expired
- 1972-03-31 US US05/239,937 patent/US3937733A/en not_active Expired - Lifetime
- 1972-03-31 FR FR7211559A patent/FR2132352B1/fr not_active Expired
- 1972-03-31 BE BE781587A patent/BE781587A/xx unknown
- 1972-04-04 NL NL7204492A patent/NL7204492A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA722184B (en) | 1972-12-27 |
| AT312795B (de) | 1974-01-25 |
| IL39005A0 (en) | 1972-05-30 |
| DK131934C (da) | 1976-03-22 |
| CA999880A (en) | 1976-11-16 |
| GB1387175A (en) | 1975-03-12 |
| AU467239B2 (en) | 1973-10-04 |
| CH579031A5 (de) | 1976-08-31 |
| US3937733A (en) | 1976-02-10 |
| FR2132352A1 (de) | 1972-11-17 |
| AU4063472A (en) | 1973-10-04 |
| BE781587A (fr) | 1972-10-02 |
| DE2117014A1 (de) | 1972-10-26 |
| FR2132352B1 (de) | 1975-04-25 |
| DK131934B (da) | 1975-09-29 |
| IL39005A (en) | 1974-12-31 |
| AT323121B (de) | 1975-06-25 |
| SE391519B (sv) | 1977-02-21 |
| NL7204492A (de) | 1972-10-04 |
| NO135181C (de) | 1977-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940005636A (ko) | 트리아졸릴티오메틸티오 세팔로스포린 염산염, 그의 수화물 결정 및 이들의 제조방법 | |
| NO135181B (de) | ||
| US20200237745A1 (en) | Aqueous drug | |
| US2132662A (en) | Aliphatic amine salts of cevitamic acid | |
| BG100709A (bg) | Кристални производни на n-ацетил невраминова киселина и методи за тяхното получаване | |
| SA517381406B1 (ar) | صور بلورية من مالتول الحديديك | |
| DE2253750A1 (de) | Neue alkaloidester vom eburnamintyp und deren salze sowie deren herstellung und diese enthaltende pharmazeutische mittel | |
| US2510993A (en) | Soluble sulfadiazene-alkali salicylate compositions | |
| US5183882A (en) | 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions | |
| US10882811B2 (en) | Synthesis of lysine acetylsalicylate glycine particles | |
| BG61368B2 (bg) | Моно(2-амониев-2-хидроксиметил-1,3-пропандиол)(2r-сis)- (3-метоксиранил)фосфонат,получаване и фармацевтични състави,които го съдържат | |
| US4048202A (en) | 3-O-Alkanoylglyceric acids | |
| NO168358B (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzofuro(3,2-c)-kinolin-forbindelser | |
| AU2016236659B2 (en) | AHU377 crystal form, preparation method and use thereof | |
| DK153486B (da) | Analogifremgangsmaade til fremstilling af krystallinsk n-formimidoyl-thienamycin-monohydrat | |
| ES2743702T3 (es) | Derivados hidroxibisfosfónicos hidrosolubles de la doxorrubicina | |
| JPH0317094A (ja) | レベカマイシン類似体の安定な溶液およびその製造 | |
| US3253990A (en) | N-methyl glucammonium salicylate and uses therefor | |
| US20150368263A1 (en) | Pharmaceutical formulations containing 3-(4-cinnamyl-l-piperazinyl) amino derivatives of 3-formylrifamycin sv and 3-formylrifamycin s and a process of their preparation | |
| US2647928A (en) | Stabilized compositions of hydroxyphenylammonium halides | |
| Butler et al. | Cinchona alkaloids in pneumonia. I. miscellaneous alkaloids and some hydrocupreine ethers | |
| US2080863A (en) | Antiseptic | |
| CN103772475A (zh) | 锥丝亚胺衍生物的盐 | |
| WO2021146341A1 (en) | Platelet storage methods and compositions | |
| CN103772383A (zh) | 吴茱萸碱衍生物的盐 |